Polyamines are ubiquitous cellular components whose functions are not known precisely although they are clearly essential for cell growth and appear to be involved in neoplastic transformation. Inhibitors of polyamine formation have great potential as therapeutic agents but a more detailed knowledge of the consequences of perturbing polyamine metabolism is needed before the full potential of these compounds can be realized. The planned experiments are centered on studies of antizyme (AZ), a protein that regulates ODC and polyamine transport and of two key enzymes in polyamine metabolism [ornithine decarboxylase (ODC) and spermidine/spermine A/1-acetyltransferase (SSAT)]. They build on studies carried out in the previous period of support that include the generation of transgenic mice in which these proteins have been over-expressed from specific promoters. In these studies, it was found: (a) that transgenic expression of AZ blocks carcinogenesis in a range of tissues in response to a variety of carcinogenic stimuli; (b) that targeted transgenic expression of SSAT increased the size and tumor incidence and progression to carcinomas of skin tumors after a two stage initiator plus promoter protocol; and (c) that there appears to be a compensatory mechanism that allows basal polyamine synthesis to occur even in the presence of enhanced levels of AZ. There are 2 specific aims.
Aim (1) will use mice expressing AZ from the K5 and K6 promoters to understand the mechanism by which AZ acts as a tumor suppressor. Experiments will be carried out to determine whether the anti-tumor effects of AZ are due solely to its ability to block increases in cellular polyamines; to determine the role of p53 in the response to AZ; to identify gene products altered by AZ expression leading to the reduction in tumor growth; and to determine whether there is a form of ODC resistant to AZ or another compensatory mechanism that occurs to allow basal polyamine levels to be maintained.
Aim 2 will use mice expressing SSAT from the K6 promoter to investigate the role of SSAT in promoting skin tumor development. The experiments will investigate three possible explanations for this effect. These are: (a) oxidative stress resulting from the activation of the SSAT/polyamine oxidase pathway; (b) the alteration in relative polyamine levels produced by SSAT; and (c) other SSAT functions not directly involved in polyamine metabolism. These experiments will extend knowledge of the control of mammalian polyamine levels, the role of polyamines in cellular physiology and the involvement of polyamines in carcinogenesis. They will also facilitate the development of inhibitors of polyamine biosynthesis including inducers of AZ as antitumor and chemopreventive agents. The knowledge generated in this research will aid in the prevention and treatment of cancer. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA018138-30A1
Application #
7029256
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Perry, Mary Ellen
Project Start
1975-12-01
Project End
2010-11-30
Budget Start
2005-12-22
Budget End
2006-11-30
Support Year
30
Fiscal Year
2006
Total Cost
$323,033
Indirect Cost
Name
Pennsylvania State University
Department
Physiology
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Keller, Ross R; Gestl, Shelley A; Lu, Amy Q et al. (2016) Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand bias. Carcinogenesis 37:810-816
Nowotarski, Shannon L; Feith, David J; Shantz, Lisa M (2015) Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines. Cancer Growth Metastasis 8:17-27
Lange, Ingo; Geerts, Dirk; Feith, David J et al. (2014) Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation. J Mol Biol 426:332-46
Koomoa, Dana-Lynn T; Geerts, Dirk; Lange, Ingo et al. (2013) DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma. Int J Oncol 42:1219-28
Feith, David J; Pegg, Anthony E; Fong, Louise Y Y (2013) Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient mice. Carcinogenesis 34:570-6
Giordano, Emanuele; Hillary, Rebecca A; Vary, Thomas C et al. (2012) Overexpression of ornithine decarboxylase decreases ventricular systolic function during induction of cardiac hypertrophy. Amino Acids 42:507-518
Welsh, Patricia A; Sass-Kuhn, Suzanne; Prakashagowda, Chethana et al. (2012) Spermine synthase overexpression in vivo does not increase susceptibility to DMBA/TPA skin carcinogenesis or Min-Apc intestinal tumorigenesis. Cancer Biol Ther 13:358-68
Shi, Chenxu; Welsh, Patricia A; Sass-Kuhn, Suzanne et al. (2012) Characterization of transgenic mice with overexpression of spermidine synthase. Amino Acids 42:495-505
Shi, Chenxu; Cooper, Timothy K; McCloskey, Diane E et al. (2012) S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion. Carcinogenesis 33:1310-8
Green, Robert; Hanfrey, Colin C; Elliott, Katherine A et al. (2011) Independent evolutionary origins of functional polyamine biosynthetic enzyme fusions catalysing de novo diamine to triamine formation. Mol Microbiol 81:1109-24

Showing the most recent 10 out of 112 publications